Fibroblasts can be activated by cytokines such as TGF-β in the tumor microenvironment and become cancer-associated fibroblasts (CAFs) that gain enhanced capacity to produce and remodel the ECM and are generally considered to promote cancer progression [38,39]. This evidence concerns the gene TGFB1 and cancer.